HAYWARD, Calif., May 23 /PRNewswire/ -- Guava Technologies, Inc. announced today that it has established a European office just outside of London in Stamford, UK. The office will focus on continuing and growing the success of Guava Technologies in this critical region (i.e., Europe, Africa, Middle East (EMEA)), and on building ever-deeper relationships with EMEA customers.
“Guava Technologies has grown significantly since it was founded in 1998, and continues to deliver innovative technologies for cell analysis to an ever-increasing number of research scientists and clinicians across numerous disciplines, including immunology, oncology, virology, and drug discovery,” said Lawrence F. Bruder, CEO and President, Guava Technologies. “Establishing a direct presence in Europe, a leading contributor to advances in life sciences, is an obvious next step in our maturation as a global player in this market.”
“The European office, which will be our EMEA headquarters, is run by Paul Wheeler, Director EMEA Operations, Guava Technologies. Our new, direct presence in EMEA is a catalyst for full optimization of support and service for our customers in this region,” said Todd Christian, VP Commercial Operations, Guava Technologies. “The new facility is a direct reflection of our commitment to the growing number of EMEA customers.”
The European office is located at 3 Southview Business Centre, Tinwell Road, Stamford, Lincs PE9 2JL, UK. “Initially it will include sales and marketing, administrative, shipping and receiving, and other operational functions,” said Paul Wheeler. “Having these functions in an office just outside of London will enable us to serve our customers more quickly and efficiently, and will put us in an ideal position to continue to grow our EMEA customer base.”
About Guava Technologies
Guava Technologies, Inc., (http://www.guavatechnologies.com), a privately-held biotechnology and medical device company, designs, develops, and delivers easy-to-use, on-demand, bench top cell analysis systems. All Systems provide absolute cell counts and offer user-friendly assay-specific software to minimize time between hypothesis and conclusion. Key products include the Guava(R) PCA & PCA-96 and Guava EasyCyte(TM) Mini & Plus Systems as well as reagent kits for cell counting/viability, antibody quantification, and apoptosis assays. Ideal for a broad range of life sciences applications, including therapeutic/diagnostic discovery, bioprocessing, quality control, cell-based research, and clinical diagnostics, Guava(R) products help scientists around the world understand life one cell at a time.
Guava, the Guava Technologies Logo, and all other trademarks are the property of Guava Technologies, Inc. (C)2007 Guava Technologies, Inc. All rights reserved.
Guava Technologies, Inc.
CONTACT: Lalit Dhir, VP of Corporate Development & Strategic Marketing,+1-510-576-1421, ldhir@guavatechnologies.com, or Lisa B. English, PhD,Communications Director, +1-510-576-1394, lenglish@guavatechnologies.com,both of Guava Technologies, Inc.
Web site: http://www.guavatechnologies.com/
